The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (21 analysts) rates it buy, with a mean price target of $80. It reported earnings in this window, a natural checkpoint for the thesis.
Semiconductor Manufacturing International Corporation 0981.HK
Clears both ethical standardsAn entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · Semiconductor Manufacturing International Corporation, an investment holding company, engages in the manufacture, testing, and sale of integrated circuits wafer and various compound semiconductors in the United States, C…
read at $71.35
Semiconductor Manufacturing International Corporation holds its Distribution at $71.35.
- PHPhase · the trend structure carries the Distribution label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · passes the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Distribution · caution |
| Quantitative state | Consolidating, no directional conviction, held for 53 days |
| Price | $71.35 |
| Valuation | 100.49 trailing · 49.81 forward price to earnings |
| Values screen | PASS |
| Beta | 0.38 |
The opportunity · what the numbers say it is worth
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish — a quality-at-a-fair-price name rather than a deep-value one.
| Revenue growth | 11.50% |
| Profit margin | 7.25% |
| Debt to equity | 40.55 |
| Analyst consensus | Buy · 21 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
This company clears both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. Here is how it did on each:
Used by most halal investing apps ✓ PASSES
The one Titan applies ✓ PASSES
What these two standards are, and how they differ →
- Business activity Its core business isn't built on prohibited lines — no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
- Debt load Interest-bearing debt is just 24.1% of its assets, well under the one-third ceiling — it does not run on borrowed money. Pass
- Interest-bearing cash Cash held in interest-bearing accounts and securities is 2.9% of assets, under the one-third limit. Pass
- Receivables Money owed to the company is 12.9% of assets, under the 49% limit. Pass
- Revenue purity Only 4.3% of revenue comes from non-compliant sources — under the 5% line. Pass
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
| Forward P/E | 49.8x expensive even after accounting for its growth |
| Trailing P/E | 100.5x expensive — the price assumes strong growth ahead |
| Revenue growth | 11.5% steady growth |
| Profit margin | 7.2% thin but positive margins |
| Return on equity | 2.6% a modest return on shareholder capital |
| Debt to equity | 0.41 minimal debt — a conservative balance sheet |
| Current ratio | 2.08 comfortably covers its short-term bills |
| Beta | 0.38 barely tracks the market's swings |
| Market cap | $610.8B |
The risks · The things to watch: its business and earnings are exposed to China and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Latest news · what the market is reading on 0981.HK
- › SMIC Q2 2026 earnings beat as AI demand drives price increases Quartz · 1d ago
- › Applied Materials Slips Despite Strong Outlook as SMIC Rallies on Earnings: Dow Jones, S&P, Nasdaq, Wall Street Futures InvestorsHub · 1d ago
- › Semiconductor Manufacturing International Corp (SHSE:688981) (Q2 2026) Earnings Call ... GuruFocus.com · 1d ago
- › China Tech Earnings Renew Focus on Hardware Stocks Over Internet Bloomberg · 2d ago
- › Chinese chipmaker SMIC increases prices on strong AI demand Reuters · 2d ago
Headlines from third-party outlets, linked for reference — not our reporting, not advice.
Related securities · others in 0981.HK's space worth a look
Screened names in the same industry · explore each on its own page.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (21 analysts) rates it buy, with a mean price target of $80. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (21 analysts) rates it buy, with a mean price target of $80. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (21 analysts) rates it buy, with a mean price target of $80. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (21 analysts) rates it buy, with a mean price target of $80. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (21 analysts) rates it buy, with a mean price target of $80. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (21 analysts) rates it buy, with a mean price target of $80. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 5.4% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (21 analysts) rates it buy, with a mean price target of $80. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 6.7% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (21 analysts) rates it buy, with a mean price target of $80.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (21 analysts) rates it buy, with a mean price target of $80.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $76.60 | -5.6% | · | $945 | -5.6% |
| 2 months | $58.25 | +24.2% | · | $1,242 | +24.2% |
| 3 months | $63.10 | +14.7% | · | $1,147 | +14.7% |
| 6 months | $67.70 | +6.9% | · | $1,069 | +6.9% |
| 1 year | $41.45 | +74.6% | · | $1,746 | +74.6% |
| 2 years | $18.38 | +293.6% | · | $3,936 | +293.6% |
| 3 years | $21.15 | +242.1% | · | $3,421 | +242.1% |
| 5 years | $23.80 | +204.0% | · | $3,040 | +204.0% |
Historical returns from market close data. Past performance does not guarantee future results.